Changing trend of empirical antibiotic regimen: Experience of two studies at different periods in a neonatal intensive care unit in Tehran, Iran

Acta Medica Iranica

Volumn 48, Issue 5, 2010, Pages 312-315

  Marzban, Asghar ^a   Samaee, Hadi ^b   Mosavinasab, Noredien ^a  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti bacterial agents; Infant; Intensive care units; Neonatal; Newborn; Therapy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CLOXACILLIN; GENTAMICIN; IMIPENEM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; ENTEROBACTER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; IRAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PREVALENCE; STAPHYLOCOCCUS AUREUS; TREND STUDY;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; HOSPITALS, TEACHING; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; IRAN; MICROBIAL SENSITIVITY TESTS; PHYSICIAN'S PRACTICE PATTERNS; SEPSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78449271957     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. th ed. London: WB Saunders; 2004. p. 623-400.
2. th ed. Philadelphia: WB Saunders; 2006. p. 248-83.
3. th ed. Philadelphia, Pa: Mosby; 2006. p. 791-825.
4. th ed. Philadelphia: Lippincott Williams & Wilkins 2004; p. 287-311.
5. Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol 1999;20(4):242-6.
6. Sidebottom DG, Freeman J, Platt R, Epstein MF, Goldmann DA. Fifteen-year experience with bloodstream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol 1988;26(4):713-8.
7. Baumgart S, Hall SE, Campos JM, Polin RA. Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child 1983;137(5):461-3.
8. Cainen G, Campognone P, Peter G. Coagulase-negative staphylococcal bacteremia in newborns. Clin Pediatr 1984;23:542-4.
9. Donowitz LG, Haley CE, Gregory WW, Wenzel RP. Neonatal intensive care unit bacteremia: emergence of gram-positive bacteria as major pathogens. Am J Infect Control 1987;15(4):141-7.
10. Freeman J, Platt R, Sidebottom DG, Leclair JM, Epstein MF, Goldmann DA. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population. Is there an epidemic? JAMA 1987;258(18):2548-52.
11. Park CH, Seo JH, Lim JY, Woo HO, Youn HS. Changing trend of neonatal infection: experience at a newly established regional medical center in Korea. Pediatr Int 2007;49(1):24-30.
12. Movahedian A, Moniri R, Mosayebi Z. Bacterial culture of neonatal sepsis. Iranian J Publ Health 2006;35(4):84-9. [Persian]
13. Samaee H. Assessing the etiology and sensitivity of causative organisms initiating bacterial sepsis in the newborn. J Med Council of Islamic Republic of Iran 1998;15:151-4. [Persian]
14. Masheof Rasoul U. Bacteriology of neonatal septicemia and antibiotic susceptibility in Hamadan hospital. J Hamadan Uni Med Sci 1999;2:136-43. [Persian]
15. Yalaz M, Cetin H, Akisu M, Aydemir S, Tunger A, Kültürsay N. Neonatal nosocomial sepsis in a level-III NICU: evaluation of the causative agents and antimicrobial susceptibilities. Turk J Pediatr 2006;48(1):13-8.
16. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B; Israel Neonatal Network. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis 2005;40(2):218-24.
17. Makhoul IR, Kassis I, Smolkin T, Tamir A, Sujov P. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001;107(1):61-6.
18. Flidel-Rimon O, Friedman S, Gradstein S, Bardenstein R, Shinwell ES. Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy. Acta Paediatr 2003;92(10):1205-7.